�ݺ�ߣshows by User: MdNazmulIslamTanmoy

�ݺ�ߣshows by User: MdNazmulIslamTanmoy / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: MdNazmulIslamTanmoy / Thu, 18 May 2023 22:37:06 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: MdNazmulIslamTanmoy Research Trends in Different Pharmaceutical Areas .pptx /slideshow/research-trends-in-different-pharmaceutical-areas-pptx/257906684 researchtrendsindifferentpharmaceuticalareasforslideshare-230518223706-4dcfd2b2
It was one of my presentation for my master's in pharmacy. It assisted me in better understanding the many pharmacy research fields as well as what to do before, during, and following a research project. I am hoping that it will also provide the readers a better understanding of the fascinating world of research.]]>
It was one of my presentation for my master's in pharmacy. It assisted me in better understanding the many pharmacy research fields as well as what to do before, during, and following a research project. I am hoping that it will also provide the readers a better understanding of the fascinating world of research.]]> Thu, 18 May 2023 22:37:06 GMT /slideshow/research-trends-in-different-pharmaceutical-areas-pptx/257906684 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Research Trends in Different Pharmaceutical Areas .pptx MdNazmulIslamTanmoy It was one of my presentation for my master's in pharmacy. It assisted me in better understanding the many pharmacy research fields as well as what to do before, during, and following a research project. I am hoping that it will also provide the readers a better understanding of the fascinating world of research. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/researchtrendsindifferentpharmaceuticalareasforslideshare-230518223706-4dcfd2b2-thumbnail.jpg?width=120&height=120&fit=bounds" /> It was one of my presentation for my master's in pharmacy. It assisted me in better understanding the many pharmacy research fields as well as what to do before, during, and following a research project. I am hoping that it will also provide the readers a better understanding of the fascinating world of research.

Research Trends in Different Pharmaceutical Areas .pptx from MdNazmulIslamTanmoy

]]> 162 0 https://cdn.slidesharecdn.com/ss_thumbnails/researchtrendsindifferentpharmaceuticalareasforslideshare-230518223706-4dcfd2b2-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Parenteral products & Insulin /slideshow/parenteral-products-insulin/250953883 parenteralproduct-220106162849
It was an assignment of mine when i was undergraduate, studying at Gono Bishwabidyalay. this assignment contains: Introduction, Definitions, Unique characteristics, categories, routes, advantages and dis-advantages. On insulin part i focused on: Introduction, different formulations of insulin, injectable insulin preparation, methods of insulin preparation, quality control of insulin, quality control parameter, common quality control tests, packaging and packaging materials..]]>
It was an assignment of mine when i was undergraduate, studying at Gono Bishwabidyalay. this assignment contains: Introduction, Definitions, Unique characteristics, categories, routes, advantages and dis-advantages. On insulin part i focused on: Introduction, different formulations of insulin, injectable insulin preparation, methods of insulin preparation, quality control of insulin, quality control parameter, common quality control tests, packaging and packaging materials..]]> Thu, 06 Jan 2022 16:28:49 GMT /slideshow/parenteral-products-insulin/250953883 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Parenteral products & Insulin MdNazmulIslamTanmoy It was an assignment of mine when i was undergraduate, studying at Gono Bishwabidyalay. this assignment contains: Introduction, Definitions, Unique characteristics, categories, routes, advantages and dis-advantages. On insulin part i focused on: Introduction, different formulations of insulin, injectable insulin preparation, methods of insulin preparation, quality control of insulin, quality control parameter, common quality control tests, packaging and packaging materials.. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/parenteralproduct-220106162849-thumbnail.jpg?width=120&height=120&fit=bounds" /> It was an assignment of mine when i was undergraduate, studying at Gono Bishwabidyalay. this assignment contains: Introduction, Definitions, Unique characteristics, categories, routes, advantages and dis-advantages. On insulin part i focused on: Introduction, different formulations of insulin, injectable insulin preparation, methods of insulin preparation, quality control of insulin, quality control parameter, common quality control tests, packaging and packaging materials..

Parenteral products & Insulin from MdNazmulIslamTanmoy

]]> 449 0 https://cdn.slidesharecdn.com/ss_thumbnails/parenteralproduct-220106162849-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 COVID-19 treatment /slideshow/covid19-treatment-250785614/250785614 covid-19treatment-211205160820
COVID-19: Introduction immunosenescence, ARDS, Hyperinflammation and mortality Cytokine storm , Inflammatory storm, Treatment of COVID-19, Acalabrunitib, Tocilizumab, Anakinra and Itolizumab, Roleof itolizumab in suppressing the cytokine storm. Approval status of Itolizumab. Treatment with the anti-CD6 MAb Itolizumab. Current status of itolizumab in the treatment of COVID-19, Common side effects of itolizumab. Expert opinion]]>
COVID-19: Introduction immunosenescence, ARDS, Hyperinflammation and mortality Cytokine storm , Inflammatory storm, Treatment of COVID-19, Acalabrunitib, Tocilizumab, Anakinra and Itolizumab, Roleof itolizumab in suppressing the cytokine storm. Approval status of Itolizumab. Treatment with the anti-CD6 MAb Itolizumab. Current status of itolizumab in the treatment of COVID-19, Common side effects of itolizumab. Expert opinion]]> Sun, 05 Dec 2021 16:08:19 GMT /slideshow/covid19-treatment-250785614/250785614 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) COVID-19 treatment MdNazmulIslamTanmoy COVID-19: Introduction immunosenescence, ARDS, Hyperinflammation and mortality Cytokine storm , Inflammatory storm, Treatment of COVID-19, Acalabrunitib, Tocilizumab, Anakinra and Itolizumab, Roleof itolizumab in suppressing the cytokine storm. Approval status of Itolizumab. Treatment with the anti-CD6 MAb Itolizumab. Current status of itolizumab in the treatment of COVID-19, Common side effects of itolizumab. Expert opinion <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/covid-19treatment-211205160820-thumbnail.jpg?width=120&height=120&fit=bounds" /> COVID-19: Introduction immunosenescence, ARDS, Hyperinflammation and mortality Cytokine storm , Inflammatory storm, Treatment of COVID-19, Acalabrunitib, Tocilizumab, Anakinra and Itolizumab, Roleof itolizumab in suppressing the cytokine storm. Approval status of Itolizumab. Treatment with the anti-CD6 MAb Itolizumab. Current status of itolizumab in the treatment of COVID-19, Common side effects of itolizumab. Expert opinion

COVID-19 treatment from MdNazmulIslamTanmoy

]]> 386 0 https://cdn.slidesharecdn.com/ss_thumbnails/covid-19treatment-211205160820-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Biopharmaceutics & Pharmacokinetics (Ultimate final note) /slideshow/biopharmaceutics-pharmacokinetics-ultimate-final-note/249866537 roll-742064ba-210727081514
Intravenous Infusion (IV): Define intravenous infusion. Write down advantages and disadvantages of intravenous infusion, Write down the pharmacokinetics of IV infusion, Calculate the plasma drug concentration at steady-state after IV infusion, Determine the half life (t1/2) by IV infusion method, Show that in case of IV infusion the time to reach 99% steady-state is 6.65 t1/2. Multiple-Dosage Regimens: Write a short note on Multiple-Dosage Regimens. What are the basic considerations for multiple dosage regimen?, What are the purposes of multiple-dosage regimens (MDR)? Write down the importance of MDR, Write short note on repetitive intravenous injections, Prove that C∞av is not arithmetic average of C∞max and C∞min, Give brief description on superposition principle and Plateau principle?. Individualization: Write down about individualization of drug dosing regimen? What are the advantages of individualization? How will you optimizing dosage regimen?, What are the sources of variability in drug response? What are the causes of Inter subject Pharmacokinetics Variability? Write down the steps involved in individualization of dosage regimen?, Write short note on – dosing of drug in obese patient and also discuss about dosing of drug in neonates, infants and children?, Write down about dosing of drug in elderly and hepatic disease? Give some examples of drugs who's conc. Changes due to hepatic impairment?, Explain some clinical experience with individualization and optimization based on plasma drug levels? NON-linear pharmacokinetics: Derive the Michaelis-Menten Equation or Non-Liner pharmacokinetic and Linear pharmacokinetic model, Define non-linear pharmacokinetics. Why it is called dose dependent pharmacokinetics?, Why Michaelis-Menten equation is termed as mixed order kinetics?, A given drug is metabolized by capacity-limited pharmacokinetics. Assume KM is 50훍g/mL, Vmax is 20훍g/mL per hour and apparent VD is 20 L/kg, Differentiate between linear & non-linear Pharmacokinetics. Non-compartment model: Briefly describe compartment model?, Briefly describe non-compartment model?, What is MRT? Write down the importance of MRT?, What is MAT? Write down the importance of MAT?, Compare between compartment model and non-compartment models.]]>
Intravenous Infusion (IV): Define intravenous infusion. Write down advantages and disadvantages of intravenous infusion, Write down the pharmacokinetics of IV infusion, Calculate the plasma drug concentration at steady-state after IV infusion, Determine the half life (t1/2) by IV infusion method, Show that in case of IV infusion the time to reach 99% steady-state is 6.65 t1/2. Multiple-Dosage Regimens: Write a short note on Multiple-Dosage Regimens. What are the basic considerations for multiple dosage regimen?, What are the purposes of multiple-dosage regimens (MDR)? Write down the importance of MDR, Write short note on repetitive intravenous injections, Prove that C∞av is not arithmetic average of C∞max and C∞min, Give brief description on superposition principle and Plateau principle?. Individualization: Write down about individualization of drug dosing regimen? What are the advantages of individualization? How will you optimizing dosage regimen?, What are the sources of variability in drug response? What are the causes of Inter subject Pharmacokinetics Variability? Write down the steps involved in individualization of dosage regimen?, Write short note on – dosing of drug in obese patient and also discuss about dosing of drug in neonates, infants and children?, Write down about dosing of drug in elderly and hepatic disease? Give some examples of drugs who's conc. Changes due to hepatic impairment?, Explain some clinical experience with individualization and optimization based on plasma drug levels? NON-linear pharmacokinetics: Derive the Michaelis-Menten Equation or Non-Liner pharmacokinetic and Linear pharmacokinetic model, Define non-linear pharmacokinetics. Why it is called dose dependent pharmacokinetics?, Why Michaelis-Menten equation is termed as mixed order kinetics?, A given drug is metabolized by capacity-limited pharmacokinetics. Assume KM is 50훍g/mL, Vmax is 20훍g/mL per hour and apparent VD is 20 L/kg, Differentiate between linear & non-linear Pharmacokinetics. Non-compartment model: Briefly describe compartment model?, Briefly describe non-compartment model?, What is MRT? Write down the importance of MRT?, What is MAT? Write down the importance of MAT?, Compare between compartment model and non-compartment models.]]> Tue, 27 Jul 2021 08:15:14 GMT /slideshow/biopharmaceutics-pharmacokinetics-ultimate-final-note/249866537 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Biopharmaceutics & Pharmacokinetics (Ultimate final note) MdNazmulIslamTanmoy Intravenous Infusion (IV): Define intravenous infusion. Write down advantages and disadvantages of intravenous infusion, Write down the pharmacokinetics of IV infusion, Calculate the plasma drug concentration at steady-state after IV infusion, Determine the half life (t1/2) by IV infusion method, Show that in case of IV infusion the time to reach 99% steady-state is 6.65 t1/2. Multiple-Dosage Regimens: Write a short note on Multiple-Dosage Regimens. What are the basic considerations for multiple dosage regimen?, What are the purposes of multiple-dosage regimens (MDR)? Write down the importance of MDR, Write short note on repetitive intravenous injections, Prove that C∞av is not arithmetic average of C∞max and C∞min, Give brief description on superposition principle and Plateau principle?. Individualization: Write down about individualization of drug dosing regimen? What are the advantages of individualization? How will you optimizing dosage regimen?, What are the sources of variability in drug response? What are the causes of Inter subject Pharmacokinetics Variability? Write down the steps involved in individualization of dosage regimen?, Write short note on – dosing of drug in obese patient and also discuss about dosing of drug in neonates, infants and children?, Write down about dosing of drug in elderly and hepatic disease? Give some examples of drugs who's conc. Changes due to hepatic impairment?, Explain some clinical experience with individualization and optimization based on plasma drug levels? NON-linear pharmacokinetics: Derive the Michaelis-Menten Equation or Non-Liner pharmacokinetic and Linear pharmacokinetic model, Define non-linear pharmacokinetics. Why it is called dose dependent pharmacokinetics?, Why Michaelis-Menten equation is termed as mixed order kinetics?, A given drug is metabolized by capacity-limited pharmacokinetics. Assume KM is 50훍g/mL, Vmax is 20훍g/mL per hour and apparent VD is 20 L/kg, Differentiate between linear & non-linear Pharmacokinetics. Non-compartment model: Briefly describe compartment model?, Briefly describe non-compartment model?, What is MRT? Write down the importance of MRT?, What is MAT? Write down the importance of MAT?, Compare between compartment model and non-compartment models. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/roll-742064ba-210727081514-thumbnail.jpg?width=120&height=120&fit=bounds" /> Intravenous Infusion (IV): Define intravenous infusion. Write down advantages and disadvantages of intravenous infusion, Write down the pharmacokinetics of IV infusion, Calculate the plasma drug concentration at steady-state after IV infusion, Determine the half life (t1/2) by IV infusion method, Show that in case of IV infusion the time to reach 99% steady-state is 6.65 t1/2. Multiple-Dosage Regimens: Write a short note on Multiple-Dosage Regimens. What are the basic considerations for multiple dosage regimen?, What are the purposes of multiple-dosage regimens (MDR)? Write down the importance of MDR, Write short note on repetitive intravenous injections, Prove that C∞av is not arithmetic average of C∞max and C∞min, Give brief description on superposition principle and Plateau principle?. Individualization: Write down about individualization of drug dosing regimen? What are the advantages of individualization? How will you optimizing dosage regimen?, What are the sources of variability in drug response? What are the causes of Inter subject Pharmacokinetics Variability? Write down the steps involved in individualization of dosage regimen?, Write short note on – dosing of drug in obese patient and also discuss about dosing of drug in neonates, infants and children?, Write down about dosing of drug in elderly and hepatic disease? Give some examples of drugs who's conc. Changes due to hepatic impairment?, Explain some clinical experience with individualization and optimization based on plasma drug levels? NON-linear pharmacokinetics: Derive the Michaelis-Menten Equation or Non-Liner pharmacokinetic and Linear pharmacokinetic model, Define non-linear pharmacokinetics. Why it is called dose dependent pharmacokinetics?, Why Michaelis-Menten equation is termed as mixed order kinetics?, A given drug is metabolized by capacity-limited pharmacokinetics. Assume KM is 50훍g/mL, Vmax is 20훍g/mL per hour and apparent VD is 20 L/kg, Differentiate between linear & non-linear Pharmacokinetics. Non-compartment model: Briefly describe compartment model?, Briefly describe non-compartment model?, What is MRT? Write down the importance of MRT?, What is MAT? Write down the importance of MAT?, Compare between compartment model and non-compartment models.

Biopharmaceutics & Pharmacokinetics (Ultimate final note) from MdNazmulIslamTanmoy

]]> 1810 0 https://cdn.slidesharecdn.com/ss_thumbnails/roll-742064ba-210727081514-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Deodorant , Antiperspirant, Perfume & Nail-polish. /slideshow/deodorant-antiperspirant-perfume-nailpolish/249834715 md-210722123540
Deodorant & Antiperspirant: Definition, properties of deodorant & antiperspirant, difference between deodorant & antiperspirant, components of sweat, odour & perspiration, deodorant action, deodorants/ingredients, formulation forms, simple formulation, evaluation of deodorant, antiperspirant action, formulation of antiperspirant sticks, active ingredients, quality control, evaluation of antiperspirant, reasons for choosing deodorant over antiperspirant. Perfume: Definition, history, notes of perfume, classification, aromatic sources, manufacturing process, composition of perfume, ingredient causing allergic reaction, psychology of using perfume. Nail-polish: Definition, facts about nail polish, anatomy of nail, preparation of nail-polish, manufacturing process, simple formula, types of nail polish, ideal character, evaluation parameters, packaging, labelling, advantages, disadvantages.]]>
Deodorant & Antiperspirant: Definition, properties of deodorant & antiperspirant, difference between deodorant & antiperspirant, components of sweat, odour & perspiration, deodorant action, deodorants/ingredients, formulation forms, simple formulation, evaluation of deodorant, antiperspirant action, formulation of antiperspirant sticks, active ingredients, quality control, evaluation of antiperspirant, reasons for choosing deodorant over antiperspirant. Perfume: Definition, history, notes of perfume, classification, aromatic sources, manufacturing process, composition of perfume, ingredient causing allergic reaction, psychology of using perfume. Nail-polish: Definition, facts about nail polish, anatomy of nail, preparation of nail-polish, manufacturing process, simple formula, types of nail polish, ideal character, evaluation parameters, packaging, labelling, advantages, disadvantages.]]> Thu, 22 Jul 2021 12:35:40 GMT /slideshow/deodorant-antiperspirant-perfume-nailpolish/249834715 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Deodorant , Antiperspirant, Perfume & Nail-polish. MdNazmulIslamTanmoy Deodorant & Antiperspirant: Definition, properties of deodorant & antiperspirant, difference between deodorant & antiperspirant, components of sweat, odour & perspiration, deodorant action, deodorants/ingredients, formulation forms, simple formulation, evaluation of deodorant, antiperspirant action, formulation of antiperspirant sticks, active ingredients, quality control, evaluation of antiperspirant, reasons for choosing deodorant over antiperspirant. Perfume: Definition, history, notes of perfume, classification, aromatic sources, manufacturing process, composition of perfume, ingredient causing allergic reaction, psychology of using perfume. Nail-polish: Definition, facts about nail polish, anatomy of nail, preparation of nail-polish, manufacturing process, simple formula, types of nail polish, ideal character, evaluation parameters, packaging, labelling, advantages, disadvantages. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/md-210722123540-thumbnail.jpg?width=120&height=120&fit=bounds" /> Deodorant & Antiperspirant: Definition, properties of deodorant & antiperspirant, difference between deodorant & antiperspirant, components of sweat, odour & perspiration, deodorant action, deodorants/ingredients, formulation forms, simple formulation, evaluation of deodorant, antiperspirant action, formulation of antiperspirant sticks, active ingredients, quality control, evaluation of antiperspirant, reasons for choosing deodorant over antiperspirant. Perfume: Definition, history, notes of perfume, classification, aromatic sources, manufacturing process, composition of perfume, ingredient causing allergic reaction, psychology of using perfume. Nail-polish: Definition, facts about nail polish, anatomy of nail, preparation of nail-polish, manufacturing process, simple formula, types of nail polish, ideal character, evaluation parameters, packaging, labelling, advantages, disadvantages.

Deodorant , Antiperspirant, Perfume & Nail-polish. from MdNazmulIslamTanmoy

]]> 2745 0 https://cdn.slidesharecdn.com/ss_thumbnails/md-210722123540-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Carcinogenesis & Mechanism of DNA repair /slideshow/carcinogenesis-mechanism-of-dna-repair/249805044 roll742064medicinalchemistrytoxicology-iiassignmentpharm4804-210719175851
Carcinogenesis Theories of carcinogenesis Hallmarks of cancer Important Oncogenes RB & p53 genes Metastasis Aetiology and Pathogenesis of cancer Tests for carcinogenicity How to repair damaged DNA? Basic DNA repair mechanism Repair of double stranded break ]]>
Carcinogenesis Theories of carcinogenesis Hallmarks of cancer Important Oncogenes RB & p53 genes Metastasis Aetiology and Pathogenesis of cancer Tests for carcinogenicity How to repair damaged DNA? Basic DNA repair mechanism Repair of double stranded break ]]> Mon, 19 Jul 2021 17:58:50 GMT /slideshow/carcinogenesis-mechanism-of-dna-repair/249805044 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Carcinogenesis & Mechanism of DNA repair MdNazmulIslamTanmoy Carcinogenesis Theories of carcinogenesis Hallmarks of cancer Important Oncogenes RB & p53 genes Metastasis Aetiology and Pathogenesis of cancer Tests for carcinogenicity How to repair damaged DNA? Basic DNA repair mechanism Repair of double stranded break <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/roll742064medicinalchemistrytoxicology-iiassignmentpharm4804-210719175851-thumbnail.jpg?width=120&height=120&fit=bounds" /> Carcinogenesis Theories of carcinogenesis Hallmarks of cancer Important Oncogenes RB & p53 genes Metastasis Aetiology and Pathogenesis of cancer Tests for carcinogenicity How to repair damaged DNA? Basic DNA repair mechanism Repair of double stranded break

Carcinogenesis & Mechanism of DNA repair from MdNazmulIslamTanmoy

]]> 1254 0 https://cdn.slidesharecdn.com/ss_thumbnails/roll742064medicinalchemistrytoxicology-iiassignmentpharm4804-210719175851-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Hydrogels /slideshow/hydrogels-249755844/249755844 hydrogelsforslideshare-210715171832
Hydrogels, introduction, historical background, properties, classification, difference between chemical and physical hydrogels, common uses, pharmaceutical applications, preparation methods, list of monomers used, analytical machines, advantages, disadvantages, conclusion]]>
Hydrogels, introduction, historical background, properties, classification, difference between chemical and physical hydrogels, common uses, pharmaceutical applications, preparation methods, list of monomers used, analytical machines, advantages, disadvantages, conclusion]]> Thu, 15 Jul 2021 17:18:32 GMT /slideshow/hydrogels-249755844/249755844 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Hydrogels MdNazmulIslamTanmoy Hydrogels, introduction, historical background, properties, classification, difference between chemical and physical hydrogels, common uses, pharmaceutical applications, preparation methods, list of monomers used, analytical machines, advantages, disadvantages, conclusion <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hydrogelsforslideshare-210715171832-thumbnail.jpg?width=120&height=120&fit=bounds" /> Hydrogels, introduction, historical background, properties, classification, difference between chemical and physical hydrogels, common uses, pharmaceutical applications, preparation methods, list of monomers used, analytical machines, advantages, disadvantages, conclusion

Hydrogels from MdNazmulIslamTanmoy

]]> 1041 0 https://cdn.slidesharecdn.com/ss_thumbnails/hydrogelsforslideshare-210715171832-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Spermatogenesis steps, hormonal regulation and abnormalities /slideshow/spermatogenesis-steps-hormonal-regulation-and-abnormalities/249703856 spermatogenesisstepshormonalregulationandabnormalities-210712170030
Spermatogenesis steps, hormonal regulation and abnormalities]]>
Spermatogenesis steps, hormonal regulation and abnormalities]]> Mon, 12 Jul 2021 17:00:30 GMT /slideshow/spermatogenesis-steps-hormonal-regulation-and-abnormalities/249703856 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Spermatogenesis steps, hormonal regulation and abnormalities MdNazmulIslamTanmoy Spermatogenesis steps, hormonal regulation and abnormalities <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/spermatogenesisstepshormonalregulationandabnormalities-210712170030-thumbnail.jpg?width=120&height=120&fit=bounds" /> Spermatogenesis steps, hormonal regulation and abnormalities

Spermatogenesis steps, hormonal regulation and abnormalities from MdNazmulIslamTanmoy

]]> 3555 0 https://cdn.slidesharecdn.com/ss_thumbnails/spermatogenesisstepshormonalregulationandabnormalities-210712170030-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Enzyme catalysed reactions, enzyme kinetics and it’s mechanism of action. /slideshow/enzyme-catalyed-reactions-enzyme-kinetics-and-its-mechanism-of-action/249527475 enzymecatalyzedreactionsenzymekineticsanditsmechanismofaction-210629072824
Enzyme catalysed reactions Enzyme kinetics, Enzyme's mechanism of action.]]>
Enzyme catalysed reactions Enzyme kinetics, Enzyme's mechanism of action.]]> Tue, 29 Jun 2021 07:28:24 GMT /slideshow/enzyme-catalyed-reactions-enzyme-kinetics-and-its-mechanism-of-action/249527475 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Enzyme catalysed reactions, enzyme kinetics and it’s mechanism of action. MdNazmulIslamTanmoy Enzyme catalysed reactions Enzyme kinetics, Enzyme's mechanism of action. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/enzymecatalyzedreactionsenzymekineticsanditsmechanismofaction-210629072824-thumbnail.jpg?width=120&height=120&fit=bounds" /> Enzyme catalysed reactions Enzyme kinetics, Enzyme's mechanism of action.

Enzyme catalysed reactions, enzyme kinetics and it’s mechanism of action. from MdNazmulIslamTanmoy

]]> 1270 0 https://cdn.slidesharecdn.com/ss_thumbnails/enzymecatalyzedreactionsenzymekineticsanditsmechanismofaction-210629072824-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 New product launching (Spli2 water purifier) /slideshow/spli2-launching-new-product/249425844 rollno-742064mr-210620182216
new product launching bangladeshi market current market situation innovative water purifier]]>
new product launching bangladeshi market current market situation innovative water purifier]]> Sun, 20 Jun 2021 18:22:15 GMT /slideshow/spli2-launching-new-product/249425844 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) New product launching (Spli2 water purifier) MdNazmulIslamTanmoy new product launching bangladeshi market current market situation innovative water purifier <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/rollno-742064mr-210620182216-thumbnail.jpg?width=120&height=120&fit=bounds" /> new product launching bangladeshi market current market situation innovative water purifier

New product launching (Spli2 water purifier) from MdNazmulIslamTanmoy

]]> 786 0 https://cdn.slidesharecdn.com/ss_thumbnails/rollno-742064mr-210620182216-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Diflunisal in geriatric /slideshow/diflunisal-in-geriatric/249420587 diflunisalingeriatric-210619102832
Diflunisal, Mechanism of action, Adverse effects Explaining “Why Diflunisal is avoided in case of geriatric patients”]]>
Diflunisal, Mechanism of action, Adverse effects Explaining “Why Diflunisal is avoided in case of geriatric patients”]]> Sat, 19 Jun 2021 10:28:31 GMT /slideshow/diflunisal-in-geriatric/249420587 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Diflunisal in geriatric MdNazmulIslamTanmoy Diflunisal, Mechanism of action, Adverse effects Explaining “Why Diflunisal is avoided in case of geriatric patients” <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/diflunisalingeriatric-210619102832-thumbnail.jpg?width=120&height=120&fit=bounds" /> Diflunisal, Mechanism of action, Adverse effects Explaining “Why Diflunisal is avoided in case of geriatric patients”

Diflunisal in geriatric from MdNazmulIslamTanmoy

]]> 207 0 https://cdn.slidesharecdn.com/ss_thumbnails/diflunisalingeriatric-210619102832-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Introduction to biopharmaceutics (Part:05) /slideshow/introduction-to-biopharmaceutics-part05/248201877 introductiontobiopharmaceuticslastpart-210510075155
E. Salt form of the drug F. Lipophilicity of the drug pH partition theory Assumption of PH partition theory Diagram showing the transfer of drug across the membrane Limitations of pH-partition hypothesis (Q.U): Mathematical problem Formulation factors affecting drug availability]]>
E. Salt form of the drug F. Lipophilicity of the drug pH partition theory Assumption of PH partition theory Diagram showing the transfer of drug across the membrane Limitations of pH-partition hypothesis (Q.U): Mathematical problem Formulation factors affecting drug availability]]> Mon, 10 May 2021 07:51:54 GMT /slideshow/introduction-to-biopharmaceutics-part05/248201877 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Introduction to biopharmaceutics (Part:05) MdNazmulIslamTanmoy E. Salt form of the drug F. Lipophilicity of the drug pH partition theory Assumption of PH partition theory Diagram showing the transfer of drug across the membrane Limitations of pH-partition hypothesis (Q.U): Mathematical problem Formulation factors affecting drug availability <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceuticslastpart-210510075155-thumbnail.jpg?width=120&height=120&fit=bounds" /> E. Salt form of the drug F. Lipophilicity of the drug pH partition theory Assumption of PH partition theory Diagram showing the transfer of drug across the membrane Limitations of pH-partition hypothesis (Q.U): Mathematical problem Formulation factors affecting drug availability

Introduction to biopharmaceutics (Part:05) from MdNazmulIslamTanmoy

]]> 285 0 https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceuticslastpart-210510075155-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Introduction to biopharmaceutics (part:04) /slideshow/introduction-to-biopharmaceutics-part-4/246283103 introductiontobiopharmaceuticspart4-210415192415
First pass effect Gastric emptying time Gastrointestinal motility Short note on Gastric emptying and motility Physicochemical factors affecting drug absorption A. Drug solubility and dissolution rate B. Particle size and surface area of drugs C. Polymorphism and amorphism D. Hydrate or solvates Biopharmaceutical classification system of drug]]>
First pass effect Gastric emptying time Gastrointestinal motility Short note on Gastric emptying and motility Physicochemical factors affecting drug absorption A. Drug solubility and dissolution rate B. Particle size and surface area of drugs C. Polymorphism and amorphism D. Hydrate or solvates Biopharmaceutical classification system of drug]]> Thu, 15 Apr 2021 19:24:15 GMT /slideshow/introduction-to-biopharmaceutics-part-4/246283103 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Introduction to biopharmaceutics (part:04) MdNazmulIslamTanmoy First pass effect Gastric emptying time Gastrointestinal motility Short note on Gastric emptying and motility Physicochemical factors affecting drug absorption A. Drug solubility and dissolution rate B. Particle size and surface area of drugs C. Polymorphism and amorphism D. Hydrate or solvates Biopharmaceutical classification system of drug <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceuticspart4-210415192415-thumbnail.jpg?width=120&height=120&fit=bounds" /> First pass effect Gastric emptying time Gastrointestinal motility Short note on Gastric emptying and motility Physicochemical factors affecting drug absorption A. Drug solubility and dissolution rate B. Particle size and surface area of drugs C. Polymorphism and amorphism D. Hydrate or solvates Biopharmaceutical classification system of drug

Introduction to biopharmaceutics (part:04) from MdNazmulIslamTanmoy

]]> 408 0 https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceuticspart4-210415192415-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Introduction to biopharmaceutics (Part:02) /slideshow/introduction-to-biopharmaceutics-part02/246048131 introductiontobiopharmaceutics2-210410180613
Circulatory system Classification of blood circulatory system Systemic Circulation Pulmonary circulation Portal circulation Physiological factors influencing drug availability Membrane physiology Mechanisms of drug absorption: Carrier mediated transport Active transport Facilitated diffusion: (Passive transport) Not-Carrier mediated transport Simple diffusion / Passive diffusion: (Passive transport)]]>
Circulatory system Classification of blood circulatory system Systemic Circulation Pulmonary circulation Portal circulation Physiological factors influencing drug availability Membrane physiology Mechanisms of drug absorption: Carrier mediated transport Active transport Facilitated diffusion: (Passive transport) Not-Carrier mediated transport Simple diffusion / Passive diffusion: (Passive transport)]]> Sat, 10 Apr 2021 18:06:13 GMT /slideshow/introduction-to-biopharmaceutics-part02/246048131 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Introduction to biopharmaceutics (Part:02) MdNazmulIslamTanmoy Circulatory system Classification of blood circulatory system Systemic Circulation Pulmonary circulation Portal circulation Physiological factors influencing drug availability Membrane physiology Mechanisms of drug absorption: Carrier mediated transport Active transport Facilitated diffusion: (Passive transport) Not-Carrier mediated transport Simple diffusion / Passive diffusion: (Passive transport) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceutics2-210410180613-thumbnail.jpg?width=120&height=120&fit=bounds" /> Circulatory system Classification of blood circulatory system Systemic Circulation Pulmonary circulation Portal circulation Physiological factors influencing drug availability Membrane physiology Mechanisms of drug absorption: Carrier mediated transport Active transport Facilitated diffusion: (Passive transport) Not-Carrier mediated transport Simple diffusion / Passive diffusion: (Passive transport)

Introduction to biopharmaceutics (Part:02) from MdNazmulIslamTanmoy

]]> 99 0 https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceutics2-210410180613-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Introduction to biopharmaceutics (part:03) /slideshow/introduction-to-biopharmaceutics-part03-245925500/245925500 introductiontobiopharmaceuticspart3-210408180325
Fick's first law Gastrointestinal (GI) Physiology Relationship between drug product and pharmacological action Definitions of Drugs: Absorption Distribution Metabolism Excretion]]>
Fick's first law Gastrointestinal (GI) Physiology Relationship between drug product and pharmacological action Definitions of Drugs: Absorption Distribution Metabolism Excretion]]> Thu, 08 Apr 2021 18:03:24 GMT /slideshow/introduction-to-biopharmaceutics-part03-245925500/245925500 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Introduction to biopharmaceutics (part:03) MdNazmulIslamTanmoy Fick's first law Gastrointestinal (GI) Physiology Relationship between drug product and pharmacological action Definitions of Drugs: Absorption Distribution Metabolism Excretion <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceuticspart3-210408180325-thumbnail.jpg?width=120&height=120&fit=bounds" /> Fick's first law Gastrointestinal (GI) Physiology Relationship between drug product and pharmacological action Definitions of Drugs: Absorption Distribution Metabolism Excretion

Introduction to biopharmaceutics (part:03) from MdNazmulIslamTanmoy

]]> 283 0 https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceuticspart3-210408180325-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Introduction to biopharmaceutics (Part:01) /slideshow/introduction-to-biopharmaceutics-part01/245061103 introductiontobiopharmaceutics-210325143252
Biopharmaceutics Pharmacokinetics Importance of Pharmacokinetics Pharmacodynamics Relationship of Pharmacokinetics & Pharmacodynamics Plasma level time curve Definition: MEC, MTC, MSC, Onset time, Tmax, Cmax. AUC ]]>
Biopharmaceutics Pharmacokinetics Importance of Pharmacokinetics Pharmacodynamics Relationship of Pharmacokinetics & Pharmacodynamics Plasma level time curve Definition: MEC, MTC, MSC, Onset time, Tmax, Cmax. AUC ]]> Thu, 25 Mar 2021 14:32:52 GMT /slideshow/introduction-to-biopharmaceutics-part01/245061103 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Introduction to biopharmaceutics (Part:01) MdNazmulIslamTanmoy Biopharmaceutics Pharmacokinetics Importance of Pharmacokinetics Pharmacodynamics Relationship of Pharmacokinetics & Pharmacodynamics Plasma level time curve Definition: MEC, MTC, MSC, Onset time, Tmax, Cmax. AUC <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceutics-210325143252-thumbnail.jpg?width=120&height=120&fit=bounds" /> Biopharmaceutics Pharmacokinetics Importance of Pharmacokinetics Pharmacodynamics Relationship of Pharmacokinetics & Pharmacodynamics Plasma level time curve Definition: MEC, MTC, MSC, Onset time, Tmax, Cmax. AUC

Introduction to biopharmaceutics (Part:01) from MdNazmulIslamTanmoy

]]> 465 0 https://cdn.slidesharecdn.com/ss_thumbnails/introductiontobiopharmaceutics-210325143252-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Adverse Drug Reaction /slideshow/adverse-drug-reaction-238913673/238913673 adr-201019122924
ADRs Classifications of ADRs Thompson and DoTS system classification Factors: age, gender, Co-morbidities, ethnicity, Pharmacogenetics,G6PD deficiency, porphyrias Immunological reactions Classifications Epidemiology and pharmacovigilance of ADRs Yellow card scheme, Thalidomide tragedy Factors that may raise or suppress suspicion of a drug]]>
ADRs Classifications of ADRs Thompson and DoTS system classification Factors: age, gender, Co-morbidities, ethnicity, Pharmacogenetics,G6PD deficiency, porphyrias Immunological reactions Classifications Epidemiology and pharmacovigilance of ADRs Yellow card scheme, Thalidomide tragedy Factors that may raise or suppress suspicion of a drug]]> Mon, 19 Oct 2020 12:29:24 GMT /slideshow/adverse-drug-reaction-238913673/238913673 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Adverse Drug Reaction MdNazmulIslamTanmoy ADRs Classifications of ADRs Thompson and DoTS system classification Factors: age, gender, Co-morbidities, ethnicity, Pharmacogenetics,G6PD deficiency, porphyrias Immunological reactions Classifications Epidemiology and pharmacovigilance of ADRs Yellow card scheme, Thalidomide tragedy Factors that may raise or suppress suspicion of a drug <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/adr-201019122924-thumbnail.jpg?width=120&height=120&fit=bounds" /> ADRs Classifications of ADRs Thompson and DoTS system classification Factors: age, gender, Co-morbidities, ethnicity, Pharmacogenetics,G6PD deficiency, porphyrias Immunological reactions Classifications Epidemiology and pharmacovigilance of ADRs Yellow card scheme, Thalidomide tragedy Factors that may raise or suppress suspicion of a drug

Adverse Drug Reaction from MdNazmulIslamTanmoy

]]> 1149 0 https://cdn.slidesharecdn.com/ss_thumbnails/adr-201019122924-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 NSAIDs (Non-steroidal anti-inflammatory drugs) /slideshow/nsaids-nonsteroidal-antiinflammatory-drugs/238899034 nsaidslidesharenew-201017071843
Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin.]]>
Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin.]]> Sat, 17 Oct 2020 07:18:43 GMT /slideshow/nsaids-nonsteroidal-antiinflammatory-drugs/238899034 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) NSAIDs (Non-steroidal anti-inflammatory drugs) MdNazmulIslamTanmoy Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nsaidslidesharenew-201017071843-thumbnail.jpg?width=120&height=120&fit=bounds" /> Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin.

NSAIDs (Non-steroidal anti-inflammatory drugs) from MdNazmulIslamTanmoy

]]> 685 0 https://cdn.slidesharecdn.com/ss_thumbnails/nsaidslidesharenew-201017071843-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Liver & Liver Diseases /slideshow/liver-liver-diseases-236793563/236793563 slideshare-200710180137
Liver liver related diseases]]>
Liver liver related diseases]]> Fri, 10 Jul 2020 18:01:37 GMT /slideshow/liver-liver-diseases-236793563/236793563 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Liver & Liver Diseases MdNazmulIslamTanmoy Liver liver related diseases <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/slideshare-200710180137-thumbnail.jpg?width=120&height=120&fit=bounds" /> Liver liver related diseases

Liver & Liver Diseases from MdNazmulIslamTanmoy

]]> 3673 0 https://cdn.slidesharecdn.com/ss_thumbnails/slideshare-200710180137-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Non-steroidal anti-inflammatory drugs (NSAID) /slideshow/nsaid-236482420/236482420 nsaidslideshare-200701190032
Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin.]]>
Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin.]]> Wed, 01 Jul 2020 19:00:32 GMT /slideshow/nsaid-236482420/236482420 MdNazmulIslamTanmoy@slideshare.net(MdNazmulIslamTanmoy) Non-steroidal anti-inflammatory drugs (NSAID) MdNazmulIslamTanmoy Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nsaidslideshare-200701190032-thumbnail.jpg?width=120&height=120&fit=bounds" /> Non-steroidal anti-inflammatory drugs, general mechanism, classifications, examples with structure activity relationship, Aspirin, Ibuprofen, Naproxen, Indomethacin.

Non-steroidal anti-inflammatory drugs (NSAID) from MdNazmulIslamTanmoy

]]> 602 0 https://cdn.slidesharecdn.com/ss_thumbnails/nsaidslideshare-200701190032-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/researchtrendsindifferentpharmaceuticalareasforslideshare-230518223706-4dcfd2b2-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/research-trends-in-different-pharmaceutical-areas-pptx/257906684 Research Trends in Dif... https://cdn.slidesharecdn.com/ss_thumbnails/parenteralproduct-220106162849-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/parenteral-products-insulin/250953883 Parenteral products & ... https://cdn.slidesharecdn.com/ss_thumbnails/covid-19treatment-211205160820-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/covid19-treatment-250785614/250785614 COVID-19 treatment